Fumarate hydratase-deficient testicular sex cord-stromal tumour (FH-TSCST): proposal for reclassification of a subset of Leydig cell tumours with distinct molecular and clinicopathologic features

Histopathology. 2023 Mar;82(4):646-647. doi: 10.1111/his.14859. Epub 2023 Jan 15.

Authors

Andres M Acosta¹, Maurizio Colecchia², Daniel M Berney³

Affiliations

¹ Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
² Department of Pathology, Università Vita-Salute San Raffaele, Milan, Italy.
³ Department of Medical Oncology, Barts Cancer Centre, Barts and the London School of Medicine and Dentistry, London, UK.

PMID: 36592067
DOI: 10.1111/his.14859

No abstract available

Keywords: HLRCC; Leydig cell tumour; fumarate hydratase; sex cord-stromal tumour; testis.

Publication types

Letter

MeSH terms

Carcinoma, Renal Cell* / pathology
Female
Fumarate Hydratase
Humans
Kidney Neoplasms* / pathology
Leydig Cell Tumor*
Male
Neoplastic Syndromes, Hereditary* / pathology
Testicular Neoplasms*
Uterine Neoplasms* / pathology

Substances

Fumarate Hydratase